Suppr超能文献

糖尿病、空腹血糖与特定病因死亡风险。

Diabetes mellitus, fasting glucose, and risk of cause-specific death.

机构信息

University of Cambridge, Cambridge, United Kingdom.

St. George's University of London, London.

出版信息

N Engl J Med. 2011 Mar 3;364(9):829-841. doi: 10.1056/NEJMoa1008862.

Abstract

BACKGROUND

The extent to which diabetes mellitus or hyperglycemia is related to risk of death from cancer or other nonvascular conditions is uncertain.

METHODS

We calculated hazard ratios for cause-specific death, according to baseline diabetes status or fasting glucose level, from individual-participant data on 123,205 deaths among 820,900 people in 97 prospective studies.

RESULTS

After adjustment for age, sex, smoking status, and body-mass index, hazard ratios among persons with diabetes as compared with persons without diabetes were as follows: 1.80 (95% confidence interval [CI], 1.71 to 1.90) for death from any cause, 1.25 (95% CI, 1.19 to 1.31) for death from cancer, 2.32 (95% CI, 2.11 to 2.56) for death from vascular causes, and 1.73 (95% CI, 1.62 to 1.85) for death from other causes. Diabetes (vs. no diabetes) was moderately associated with death from cancers of the liver, pancreas, ovary, colorectum, lung, bladder, and breast. Aside from cancer and vascular disease, diabetes (vs. no diabetes) was also associated with death from renal disease, liver disease, pneumonia and other infectious diseases, mental disorders, nonhepatic digestive diseases, external causes, intentional self-harm, nervous-system disorders, and chronic obstructive pulmonary disease. Hazard ratios were appreciably reduced after further adjustment for glycemia measures, but not after adjustment for systolic blood pressure, lipid levels, inflammation or renal markers. Fasting glucose levels exceeding 100 mg per deciliter (5.6 mmol per liter), but not levels of 70 to 100 mg per deciliter (3.9 to 5.6 mmol per liter), were associated with death. A 50-year-old with diabetes died, on average, 6 years earlier than a counterpart without diabetes, with about 40% of the difference in survival attributable to excess nonvascular deaths.

CONCLUSIONS

In addition to vascular disease, diabetes is associated with substantial premature death from several cancers, infectious diseases, external causes, intentional self-harm, and degenerative disorders, independent of several major risk factors. (Funded by the British Heart Foundation and others.).

摘要

背景

糖尿病或高血糖与癌症或其他非血管疾病死亡风险的关系程度尚不确定。

方法

我们根据 97 项前瞻性研究中 820900 人的个体参与者数据,计算了基线时糖尿病状态或空腹血糖水平与特定原因死亡的风险比。

结果

在调整年龄、性别、吸烟状况和体重指数后,与无糖尿病者相比,糖尿病患者的以下风险比如下:1.80(95%置信区间[CI],1.71 至 1.90)死于任何原因,1.25(95%CI,1.19 至 1.31)死于癌症,2.32(95%CI,2.11 至 2.56)死于血管原因,1.73(95%CI,1.62 至 1.85)死于其他原因。糖尿病(与无糖尿病)与肝癌、胰腺癌、卵巢癌、结直肠癌、肺癌、膀胱癌和乳腺癌的死亡中度相关。除癌症和血管疾病外,糖尿病(与无糖尿病)还与肾病、肝病、肺炎和其他传染病、精神障碍、非肝消化疾病、外部原因、故意自残、神经系统疾病和慢性阻塞性肺疾病的死亡相关。进一步调整血糖测量值后,风险比显著降低,但调整收缩压、血脂水平、炎症或肾脏标志物后则没有降低。空腹血糖水平超过 100mg/dL(5.6mmol/L),而不是 70 至 100mg/dL(3.9 至 5.6mmol/L),与死亡相关。一个 50 岁的糖尿病患者平均比无糖尿病的同龄人早死 6 年,其中约 40%的生存差异归因于非血管死亡过多。

结论

除血管疾病外,糖尿病与多种癌症、传染病、外部原因、故意自残和退行性疾病的过早死亡密切相关,且独立于多个主要危险因素。(由英国心脏基金会等资助)。

相似文献

1
Diabetes mellitus, fasting glucose, and risk of cause-specific death.
N Engl J Med. 2011 Mar 3;364(9):829-841. doi: 10.1056/NEJMoa1008862.
4
Glucose levels and risk of dementia.
N Engl J Med. 2013 Aug 8;369(6):540-8. doi: 10.1056/NEJMoa1215740.
5
Normal fasting plasma glucose levels and type 2 diabetes in young men.
N Engl J Med. 2005 Oct 6;353(14):1454-62. doi: 10.1056/NEJMoa050080.
7
[Number of deaths that attributable to high fasting plasma glucose among population aged 25 and above and its impact on life expectancy in China, 2013].
Zhonghua Liu Xing Bing Xue Za Zhi. 2017 Aug 10;38(8):1028-1032. doi: 10.3760/cma.j.issn.0254-6450.2017.08.006.
8
Fasting serum glucose level and cancer risk in Korean men and women.
JAMA. 2005 Jan 12;293(2):194-202. doi: 10.1001/jama.293.2.194.
10
From policemen to policies: what is the future for 2-h glucose? The Kelly West Lecture, 2000.
Diabetes Care. 2001 Nov;24(11):1945-50. doi: 10.2337/diacare.24.11.1945.

引用本文的文献

2
Routine Laboratory Markers-Based Machine Learning Model for Predicting Severe Kawasaki Disease in Pediatric Patients.
J Inflamm Res. 2025 Aug 4;18:10545-10558. doi: 10.2147/JIR.S528341. eCollection 2025.
4
Link between type 2 diabetes mellitus and hepatocellular carcinoma.
World J Hepatol. 2025 Jul 27;17(7):107675. doi: 10.4254/wjh.v17.i7.107675.
6
Prediabetes.
Nat Rev Dis Primers. 2025 Jul 17;11(1):49. doi: 10.1038/s41572-025-00635-0.
7
Gene mutation in cancer patients with diabetes: a real-world retrospective cohort study.
BMC Cancer. 2025 Jul 10;25(1):1163. doi: 10.1186/s12885-025-14511-3.
8
Asian Pacific Society of Nephrology Clinical Practice Guideline on Diabetic Kidney Disease-2025 Update.
Nephrology (Carlton). 2025 Jul;30 Suppl 2(Suppl 2):3-56. doi: 10.1111/nep.70030.
10
Response to therapy with direct antiviral drugs in HCV-infected patients with diabetes.
Sci Rep. 2025 Jul 1;15(1):20936. doi: 10.1038/s41598-025-06290-5.

本文引用的文献

1
Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials.
Lancet. 2010 Nov 20;376(9754):1741-50. doi: 10.1016/S0140-6736(10)61543-7. Epub 2010 Oct 21.
3
Body-mass index and cancer mortality in the Asia-Pacific Cohort Studies Collaboration: pooled analyses of 424,519 participants.
Lancet Oncol. 2010 Aug;11(8):741-52. doi: 10.1016/S1470-2045(10)70141-8. Epub 2010 Jun 30.
4
Diabetes and cancer: a consensus report.
CA Cancer J Clin. 2010 Jul-Aug;60(4):207-21. doi: 10.3322/caac.20078. Epub 2010 Jun 16.
5
Diabetes, prediabetes and cancer mortality.
Diabetologia. 2010 Sep;53(9):1867-76. doi: 10.1007/s00125-010-1796-7. Epub 2010 May 21.
6
Risk of cancer in a large cohort of U.S. veterans with diabetes.
Int J Cancer. 2011 Feb 1;128(3):635-43. doi: 10.1002/ijc.25362.
7
Statistical methods for the time-to-event analysis of individual participant data from multiple epidemiological studies.
Int J Epidemiol. 2010 Oct;39(5):1345-59. doi: 10.1093/ije/dyq063. Epub 2010 May 3.
8
C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis.
Lancet. 2010 Jan 9;375(9709):132-40. doi: 10.1016/S0140-6736(09)61717-7. Epub 2009 Dec 22.
10
Metformin associated with lower cancer mortality in type 2 diabetes: ZODIAC-16.
Diabetes Care. 2010 Feb;33(2):322-6. doi: 10.2337/dc09-1380. Epub 2009 Nov 16.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验